Malaria causes much physical and economic hardship in tropical regions, particularly in
communities where medical care is rudimentary. Should a vaccine be developed, it is the …

More attention is being focused on malaria today than any time since the world's last efforts
to achieve eradication over 40 years ago. The global community is now discussing …

Background Plasmodium vivax invasion requires interaction between the human Duffy
antigen on the surface of erythrocytes and the P. vivax Duffy binding protein (PvDBP) …

Plasmodium vivax is one of four Plasmodium species that cause human malaria. P. vivax
and a related simian malaria parasite, Plasmodium knowlesi, invade erythrocytes by binding …

Malaria merozoite invasion of human erythrocytes depends on recognition of specific
erythrocyte surface receptors by parasite ligands. Plasmodium vivax merozoite invasion is …

The receptor-binding domain, region II, of the Plasmodium vivax Duffy binding protein
(PvDBPII) binds the Duffy antigen on the reticulocyte surface to mediate invasion. A …

Introduction Plasmodium vivax causes significant public health problems in endemic
regions. A vaccine to prevent disease is critical, considering the rapid spread of drug …

Erythrocyte invasion by malaria parasites is essential for blood-stage development and an
important determinant of host range. In Plasmodium vivax, the interaction between the Duffy …

Malaria parasites make specific receptor–ligand interactions to invade erythrocytes. A 175
kDa Plasmodium falciparum erythrocyte binding antigen (EBA-175) binds sialic acid …

Plasmodium vivax depends on interaction with the Duffy antigen/receptor for chemokines
(DARC) for invasion of human erythrocytes. The 140 kDa P. vivax Duffy‐binding protein …